The occurrence of vaccine-associated paralytic poliomyelitis in Brazil, 1995 to 2001;Ocorrência de poliomielite associada à vacina no Brasil, 1995 a 2001

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 18, Issue 1, 2005, Pages 21-24

  Teixeira Rocha, Eduardo Souza ^a,b   Carmo, Eduardo Hage ^c   Tavares Neto, José ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Ministério da Saúde ^*  (Brazil)

^c MINISTÉRIO DA SAÚDE   (Brazil)

Author keywords

Brazil; Poliovirus vaccine, oral; Risk

Indexed keywords

POLIOMYELITIS VACCINE;

DISEASE CONTROL; DISEASE TREATMENT; POLIOMYELITIS; VACCINATION;

ARTICLE; BRAZIL; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HEALTH CARE POLICY; HUMAN; INCIDENCE; INFANT; MALE; POLIOMYELITIS; VACCINATION;

BRAZIL; SOUTH AMERICA; WESTERN HEMISPHERE; WORLD;

POLIOVIRUS;

EID: 23744503490     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892005000600004     Document Type: Article

References (17)

1. Sabin AB. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis. 1985;151(3):420-36.
2. Henderson DA, Witte JJ, Morris L, Langmuir AD. Paralytic disease associated with oral polio vaccines. JAMA. 1964;190:41-8.
3. Nkowane BM, Wassilak SGF, Orenstein WA. Vaccine-associated paralytic poliomyelitis. JAMA. 1987;257(10):1335-40.
4. De Oliveira LH, Struchiner CJ. Vaccine-associated paralytic poliomyelitis in Brazil, 1989-1995. Rev Panam Salud Publica. 2000; 7(4):219-24.
5. Prevots RD, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994;148(5):479-85.
6. Brasil, Ministério da Saúde. Guia de vigilância epidemiológica. Brasília: Ministério da Saúde; 2003.
7. Brasil, Ministério da Saúde. DataSUS-Tecnologia da Informação a serviço do SUS. Imunizações-Doses aplicadas. Disponível em: http://tabnet.datasus.gov.br/cgi/pni/ dpnimap.htm. Acessado em 28 de setembro de 2003.
8. Centers for Disease Control and Prevention. Notice to readers: Recommended childhood immunization schedule, change in polio vaccination recommendations: sequential polio vaccination schedule, United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46(2): 35-40.
9. Prevots DR, Burr RK, Sutter RW, Murphy TV; Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-5): 1-22.
10. Abraham R, Minor P, Dunn G, Modlin JF, Ogra PL. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis. 1993;168(5):1105-9.
11. Weibel RE, Benor DE. Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and National Vaccine Injury Compensation Program. Am J Public Health. 1996;86(5):734-7.
12. Andrus JK, Stebel PM, de Quadros CA, Olive JM. Risk of vaccine-associated poliomyelitis in Latin America, 1989-91. Bull World Health Organ. 1995;73(1):33-40.
13. World Health Organization. Global Polio Eradication Initiative-Progress 2002. Genebra: WHO, Department of Vaccines and Biologicals; 2003. (WHO/POLIO/03.02).
14. World Health Organization. Global action plan for laboratory containment of wild polioviruses. Genebra: WHO, Department of Vaccines and Biologicals; 1999. (WHO/V&B/ 99.32).
15. World Health Organization. New polio vaccines for the post-eradication era. Geneva: WHO; 2000.
16. World Health Organization, Technical Consultative Group. Report of the interim meeting of the Technical Consultative Group on the Global Eradication of Poliomyelitis. Geneva: WHO; 2002.
17. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ. 2004; 82(1):16-23.